Literature DB >> 18067026

Parvovirus B19 acute infection and a reactivation of cytomegalovirus and herpesvirus 6 in a chronic myeloid leukemia patient during treatment with dasatinib (BMS-354825).

Ricardo García-Muñoz, Alicia Galar, Cristina Moreno, Paula Rodríguez-Otero, Elena Panizo-Morgado, Mariano Ponz-Sarvisê, Mirian Fernandez-Alonso, Manuel Rubio, Juana Merino, Braulia Cuesta, Carlos Panizol, Felipe Prosper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18067026     DOI： 10.1080/10428190701671044

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  5 in total

1.  Tyrosine kinase inhibitors impair B-cell immune responses in CML through off-target inhibition of kinases important for cell signaling.

Authors:  Hugues de Lavallade; Ahmad Khoder; Melanie Hart; Anushruti Sarvaria; Takuya Sekine; Abdullah Alsuliman; Stephan Mielke; Alexandra Bazeos; Kate Stringaris; Sara Ali; Dragana Milojkovic; Letizia Foroni; Aristeidis Chaidos; Nichola Cooper; Ian Gabriel; Jane Apperley; Sarah Belsey; Robert J Flanagan; John Goldman; Elizabeth J Shpall; Peter Kelleher; David Marin; Katayoun Rezvani
Journal:  Blood       Date:  2013-05-29       Impact factor: 22.113

2.  Severe Refractory Anaemia and Fever of Unknow Origin: Human Parvovirus B19 Reactivation.

Authors:  Joaquín Escobar-Sevilla; Antonio Bustos Merlo; Carmen Garcia Martínez; Juan Diego Mediavilla Garcia
Journal:  Eur J Case Rep Intern Med       Date:  2020-06-25

3.  Acute Onset of Remitting Seronegative Symmetrical Synovitis With Pitting Edema (RS3PE) Two Weeks After COVID-19 Vaccination With mRNA-1273 With Possible Activation of Parvovirus B19: A Case Report With Literature Review.

Authors:  Hiroto Arino; Naokazu Muramae; Mitsumasa Okano; Kenta Mori; Kazunori Otsui; Kazuhiko Sakaguchi
Journal:  Cureus       Date:  2022-05-12

4.  Successful prior treatment with dasatinib followed by stem cell transplantation in a patient with CML in blastic crisis with a BCR-ABL mutation.

Authors:  Moritaka Gotoh; Tetsuzo Tauchi; Seiichiro Yoshizawa; Toshihiko Kitahara; Toru Kiguchi; Yukihiko Kimura; Kazuma Ohyashiki
Journal:  Int J Hematol       Date:  2010-01-05       Impact factor: 2.490

Review 5.  Risk of Infectious Complications in Hemato-Oncological Patients Treated with Kinase Inhibitors.

Authors:  Mark Reinwald; Tobias Boch; Wolf-Karsten Hofmann; Dieter Buchheidt
Journal:  Biomark Insights       Date:  2016-04-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.